The direct transfer of Treg cells suppresses the function of macrophages and inhibits effector T cell function in islets in a TGF-β-dependent manner, which lays the rational foundation of Treg-based T1D therapies [122]. Here, TGFB1 is linked to type 1 diabetes mellitus.